A newly characterized class of sulfur-rich poly(trisulfide) polymers has demonstrated broad-spectrum antimicrobial activity while selectively sparing human cells - a performance profile that materials scientists and automotive interior specialists are evaluating as a potential foundation for next-generation surface coatings.
Research led by Professor Justin Chalker's group at Flinders University, in collaboration with UK experts and published in Chemical Science, details how poly(trisulfide) oligomers synthesized via photochemical ring-opening polymerization exhibited potent antifungal activity against Candida albicans (MIC < 8 µg/mL) and inhibited the Gram-positive bacterium Staphylococcus aureus (MIC = 16 µg/mL). Critically, the molecular design of these poly(trisulfide) oligomers allows them to selectively target microbial cells while sparing human and plant cells - a distinction that addresses one of the central barriers to occupied-space applications such as automotive cabins.
Background
Advances in sulfur polymer chemistry have enabled novel sulfur-rich materials with antimicrobial activity, though most have historically been water-insoluble, limiting their use in biomedical and applied coating contexts. The field gained momentum through inverse vulcanization - a bulk polymerization method that converts elemental sulfur, an abundant petrochemical byproduct, into stable functional polymers. More than 60 million tons of sulfur are produced annually as a petrochemical byproduct, and the inverse vulcanization process transforms this excess into functional polymers by stabilizing it with organic cross-linkers.
Interest in polysulfides as antimicrobial agents draws on the well-documented biocidal activity of natural organosulfur compounds found in garlic and onions. The World Health Organization has identified Staphylococcus aureus and Pseudomonas aeruginosa as priority pathogens for antimicrobial development. Earlier work from the University of Liverpool reported a bacteria log reduction greater than log 4.3 of adhered S. aureus cells on inverse vulcanized sulfur polymer surfaces, reinforcing the surface-coating potential of this chemistry.
Within the automotive sector, demand for hygiene-functional surfaces has increased, particularly following growth in shared mobility. As shared-use models expand, more people come into regular contact with high-use surfaces, creating conditions for bacteria, viruses, and other microorganisms to thrive - with applications spanning car-sharing interiors and public transport.1Comparative antibacterial and antifungal activities of sulfur nanoparticles capped with chitosan - PubMed Meanwhile, conventional antimicrobial silver technologies face challenges meeting the European Chemicals Agency (ECHA) review requirements.2Innovative Antibacterial Polymer Coatings
Regulatory and Technical Details
The core regulatory obstacle for sulfur-based biocidal polymers in Europe is the EU Biocidal Products Regulation (BPR), Regulation (EU) No 528/2012. The regulation establishes a two-tier system: active substances must first receive EU-level approval, after which individual biocidal products containing them require authorization either nationally or through a Union authorization procedure. A biocidal product must be authorized before it can be made available on the market or used in the European Economic Area and Switzerland. For novel polymer architectures, this means initiating a new active substance dossier from scratch - a process requiring the Biocidal Products Committee (BPC) to deliver its opinion within 270 days of dossier submission before a European Commission decision can follow.
Biocompatibility presents a parallel challenge. Interior surface coatings that contact vehicle occupants must satisfy ISO 10993-series cytotoxicity and sensitization standards, along with OEM-specific qualification tests covering UV stability, VOC/fogging performance to ISO 12219, and abrasion resistance. Sulfur polymers are generally unstable under UV irradiation owing to breakdown into hydrophilic compounds - a recognized limitation that research groups are addressing through comonomer selection. Researchers at University College London have demonstrated that synthesizing a sulfur polymer using a siloxane monomer (poly(S-TVTSi)) produces a material capable of withstanding UV exposure while maintaining photocatalytic activity, opening a pathway to more durable exterior-grade coatings.
Published data on mechanism of action suggest that, because no significant sulfur-containing material leaches from cross-linked inverse vulcanized polymers and the polymers retain an amorphous character, the most likely antimicrobial mechanism is homolytic bond cleavage - a feature desirable for long-term antibacterial surfaces. Non-leaching contact-kill activity reduces concerns about concentration gradients, depletion over time, and antimicrobial resistance (AMR) development associated with release-based systems.
Performance standards applicable to automotive trim - notably ISO 22196, which governs the measurement of antibacterial activity on plastics and non-porous surfaces, and ECHA BPR compliance requirements - define the technical benchmarks sulfur-based coating candidates must meet before commercial qualification.
Outlook
Near-term progress hinges on resolving the water-solubility challenges of sulfur polymer formulations required for solution-processing and coating deposition. Researchers have synthesized a linear poly(trisulfide) via photochemical ring-opening polymerization of a cyclic trisulfide monomer bearing a carboxylic acid, where deprotonation renders the poly(trisulfide) fully water-soluble with concomitant chain scission via S-S cleavage - a step that could enable aqueous-based coating processes compatible with existing automotive finishing lines. If BPR active substance dossiers are initiated soon, conservative estimates place regulatory approval and initial OEM pilot integration no earlier than the late 2020s, given ECHA's new active substance review timelines and the additional time required for automotive material qualification and Tier-1 supplier validation. Cross-sector demand from healthcare and agricultural coatings applications is expected to accelerate dossier investment and commercial scale-up of the underlying polymer chemistry.
